Dr. Ana Maria Lopez, MD, MPH, MACP

Media Releases

Get to know Medical Oncologist Dr. Ana Maria Lopez, who serves patients in Philadelphia, Pennsylvania.

Dr. Lopez is Professor and Vice Chair of Medical Oncology & Chief of Cancer Services at Sidney Kimmel Cancer Center – Jefferson Health in Philadelphia, Pennsylvania. She brings her expertise in breast and gynecologic cancers, integrative medicine, telehealth, and cancer disparities with her to her work at the Sidney Kimmel Cancer Center of Thomas Jefferson University.

Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A medical professional who practices oncology is an oncologist. An oncologist is a doctor who treats cancer and provides medical care for a person diagnosed with cancer. They lead a cancer treatment team of various healthcare professionals, treat patients with medical approaches to care, coordinate treatment plans and prescribe various types of treatment, including chemotherapy and immunotherapy, as well as assist patients with pain management.

The Sidney Kimmel Cancer Center is committed to person-focused, multidisciplinary cancer care where nationally renowned cancer experts provide care for patients with all types of cancers, including cancers of the lung, colon and rectum, breast, pancreas, stomach, esophagus, prostate, bladder and head and neck, as well as melanoma, leukemia, lymphoma and multiple and uveal myeloma. The Center also performs autologous and allogeneic bone marrow transplantation for selected forms of cancer.

Dr. Lopez sees herself as an ameliorist, one who seeks to make things better. Her career trajectory demonstrates this commitment to care and to making better care accessible to more people. Following undergraduate studies in Philosophy at Bryn Mawr College, she earned her medical degree from Sidney Kimmel Medical College of Thomas Jefferson University. She then trained in internal medicine and hematology-oncology, completed a Master of Public Health degree in Health Policy and Administration, and was awarded a Cancer Prevention and Etiology Fellowship (T32, NCI) at the University of Arizona and the Arizona Cancer Center.

Subsequently, she joined the faculty of the University of Arizona College of Medicine and earned tenure and the academic rank of professor. She also served as medical director of the Women’s Health Initiative, founding medical director of the Arizona Telemedicine Program, and associate dean of outreach and multicultural affairs.

In 2015, Dr. Lopez moved to University of Utah Health Sciences, where she served as a professor of medicine at the University of Utah School of Medicine, director of cancer health equity at the Huntsman Cancer Institute, and associate vice president for health equity and inclusion at University of Utah Health Sciences. 

Dr. Lopez was recruited to the Sidney Kimmel Cancer Center in 2018 where she joined the faculty of the Sidney Kimmel Medical College and is affiliated with Thomas Jefferson University Hospital, Jefferson Health New Jersey, and Jefferson Methodist Hospital.

With a commitment to excellence, Dr. Lopez is board-certified in medical oncology and hematology/oncology by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

Among her professional affiliations, Dr. Lopez is President Emeritus and Master of the American College of Physicians; member of the Education Committee and of the Telemedicine Standards Committee of the American Society of Clinical Oncology; and member of the Steering Committee, Group on Women In Medicine and Science, Association of American Medical Colleges. Dr. Lopez formerly served on the Board of the National Hispanic Medical Association, and is past-Chair of the Cancer Health Disparities Committee of the American Society of Clinical Oncology.

Recognized for her expertise in cancer prevention and telemedicine, Dr. Lopez has approximately 100 peer-reviewed journal articles and multiple book chapters. She has dedicated her career to addressing health inequities through community-based participatory research and through clinical trials that assess telecommunications technology to facilitate access to clinical care and education. She served as a member of Patient-Centered Outcomes Research Institute (PCORI) Advisory Panel, Healthcare Delivery and Disparities Research from August 2016 to August 2019.

Recommended Articles

• Prostate Cancer: What Are the Symptoms If It Is Not Asymptomatic?

  Prostate cancer tends to affect only men. The incidence of prostate cancer is on the increase and tends to be more common in the western world. The causes of prostate cancer are poorly understood. However, risks factors include a positive family history, environmental and dietary factors. The...

• This Drug Significantly Stops Cell Growth in Metastatic Breast Cancer

  HER2-negative metastatic breast cancer is a common yet incurable disease that has spread from the breast to other parts of a person’s body. It’s an aggressive cancer that usually affects the breast plus a patient's bone, lungs, liver and brain. Even when breast cancer spreads into other parts of...

• BRCA Gene Risk Status Identified for Ovarian Cancer

  It is well-known in the medical community that a specific genetic mutation can increase your risk of getting ovarian cancer and breast cancer. These genes are commonly known as BRCA1 and BRCA 2. While it is more likely that you’ll get ovarian cancer if you happen to have this genetic abnormality,...

• Treatments for Liver Cancer

  During liver cancer treatment, different healthcare professionals work together to come up with an overall treatment plan. The treatment plan combines different types of cancer treatment to get a successful cure. This group of doctors is called a "multidisciplinary team", which include:...

• How #Cancerland Changed New York Fashion Week

  New York Fashion Week is a prestigious event that is held every year in the months of February and September. It shows off the latest fashion collections from renown designers, exhibited by the world’s most successful models. This year, AnoOno came together with #Cancerland, a U.S. non-profit...

• 17 Years After September 11, 2001, FBI Agent Battles Lymphoma With the Help of the Sentara Cancer Network

  FBI explosives expert, Thomas Mohnal, has been witness to a lot of horrific cases in his line of work. The Unabomber case, Embassy bombing in Africa, plane crashes that happened in New York and Mexico – the list goes on and on.  ...